SCHEMBL19978199

SCHEMBL19978199

C=C/C=C(\CC)NC(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.35
CA7 P43166 2/20 0.35
CA12 O43570 2/20 0.35
CA14 Q9ULX7 2/20 0.35
TDP1 Q9NUW8 1/20 0.34
CTSK P43235 7/20 0.33
CA2 P00918 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
CTSS P25774 1/20 0.32
APLNR P35414 1/20 0.32
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24223538 0.82 CTSK (0.40) CA1CA7CA12CA14TDP1
SCHEMBL20729425 0.80 TDP1 (0.35) TDP1MEN1KMT2AGAAALDH1A1
SCHEMBL18939701 0.80 TDP1 (0.50) CA1CA7CA12CA14TDP1
SCHEMBL19978200 0.79 CA1 (0.37) CA1CA7CA12CA14TDP1
SCHEMBL19823872 0.77 CA1 (0.36) CA1CA7CA12CA14TDP1
SCHEMBL22168208 0.77 CA1 (0.35) CA1CA7CA12CA14TDP1
SCHEMBL22212613 0.77 MEN1 (0.35) CA1CA7CA12CA14TDP1
SCHEMBL20036882 0.77 NFKB1 (0.33) CA1CA7CA12CA14TDP1
SCHEMBL28465962 0.76 CA1 (0.38) CA1CA7CA12CA14TDP1
SCHEMBL23745122 0.74 ALDH1A1 (0.36) TDP1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109918-A1 NITROGENOUS HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 中国科学院上海药物研究所 2023-06-22 WO disclosed
WO-2022076975-A1 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES ENLIVEN THERAPEUTICS, INC. (US) 2022-04-14 WO disclosed
WO-2021018194-A1 HETEROCYCLIC COMPOUNDS AS BCR-ABL INHIBITORS ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) 2021-02-04 WO disclosed
WO-2018053240-A1 PEPTIDOMIMETICS AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2018-03-22 WO disclosed